BridgeMD
New treatment option for Breast Cancer
Official title Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
ClinicalTrials.gov ID: NCT07166042
What this study is testing
- What it's testing
- The goal of this study is to assess the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant aged ≥ 18 years.
- Diagnosis of breast or gynelogical cancer.
- Eligible to receive 15-25 daily radiation therapy treatments for breast or gynelogical cancer.
- Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
- Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
You likely can't join if
- Active suicidal ideation or active psychotic state in the opinion of the investigator.
- Patient is receiving deep inspiration breath hold treatment.
- An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
- Prior radiation therapy.
- Inability to understand and/or speak the English language.
See the full eligibility criteria
- Participant aged ≥ 18 years.
- Diagnosis of breast or gynelogical cancer.
- Eligible to receive 15-25 daily radiation therapy treatments for breast or gynelogical cancer.
- Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
- Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
- Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.
- Active suicidal ideation or active psychotic state in the opinion of the investigator.
- Patient is receiving deep inspiration breath hold treatment.
- An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
- Prior radiation therapy.
- Inability to understand and/or speak the English language.
The study team makes the final eligibility decision.
Where it's taking place
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.